Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3827200 | Revista Clínica Española | 2013 | 6 Pages |
Abstract
In patients with RVO, it may be recommendable to control classical VRF and measure serum homocysteine levels. Our data also suggest that antiphospholipid syndrome should be ruled out and that a study of thrombophilia should only be considered in subjects aged <50 years or without VRF. Antiplatelet therapy with aspirin is the treatment of choice to reduce the overall vascular risk. Anticoagulation should only be considered in those patients with high-risk thrombophilias.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
J.J. Napal Lecumberri, C. Sedano Balbas, J. Cañal Villanueva, J.L. Hernández Hernández,